Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001701523-18-000002
Filing Date
2018-12-17
Accepted
2018-12-17 13:50:32
Documents
1
Effectiveness Date
2018-12-17
Items
Item 04.3: Rule 504(b)(1)(iii)
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4668
  Complete submission text file 0001701523-18-000002.txt   5721
Mailing Address 327 ST MARKS AVE BROOKLYN NY 11238
Business Address 327 ST MARKS AVE BROOKLYN NY 11238 6094971282
Illuminare Biotechnologies Inc (Filer) CIK: 0001701523 (see all company filings)

EIN.: 812564534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-328120 | Film No.: 181237688